Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Withdrawn1

Active, not recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (20.0%)

N/A4 (80.0%)

Trials by Status

completed240%

withdrawn120%

active_not_recruiting120%

not_yet_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

The Ability of Pecan Consumption to Improve Vascular Function and Reduce Chronic Disease Risk in Aging Adults

NCT04385537

completednot_applicable

Acute Consumption of Pecan-enriched Meal

NCT04849962

Clinical Trials (5)

Showing 5 of 5 trials

NCT06879626Not Applicable

Effect of Snacks on Aging

Active Not Recruiting

NCT07696403Not Applicable

Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose

Not Yet Recruiting

NCT04487808Phase 2

Diet Quality, Pecans, and Cardiometabolic Health

Withdrawn

NCT04385537Not Applicable

The Ability of Pecan Consumption to Improve Vascular Function and Reduce Chronic Disease Risk in Aging Adults

Completed

NCT04849962Not Applicable

Acute Consumption of Pecan-enriched Meal

Completed

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5